STOCK TITAN

SelectQuote Inc - SLQT STOCK NEWS

Welcome to our dedicated news page for SelectQuote (Ticker: SLQT), a resource for investors and traders seeking the latest updates and insights on SelectQuote.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect SelectQuote's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of SelectQuote's position in the market.

Rhea-AI Summary
SelectQuote, Inc. (NYSE: SLQT) reported consolidated revenue for the second quarter of fiscal year 2024 of $405.4 million, compared to $319.2 million for the same period in 2023. Net income was $19.4 million, and Adjusted EBITDA was $67.4 million. The company raised its fiscal year 2024 guidance ranges, with revenue expected in a range of $1.23 billion to $1.3 billion and net loss expected in a range of $45 million to $22 million. The Senior segment's revenue was $247.5 million, with Adjusted EBITDA of $78.7 million and approved Medicare Advantage policies of 234,576. Healthcare Services revenue was $111.7 million, with Adjusted EBITDA of $3.0 million and over 62,000 SelectRx members. Life segment revenue was $37.4 million, and Auto & Home segment revenue was $10.5 million. The CEO expressed confidence in the company's strategy and outlook for fiscal year 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.9%
Tags
-
Rhea-AI Summary
SelectQuote, Inc. (NYSE: SLQT) will release its fiscal second quarter 2024 financial results on February 7, 2024. The Chief Executive Officer and Chief Financial Officer will host a conference call to discuss the results. Registration for the call is open, and it will also be webcasted live.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.54%
Tags
-
Rhea-AI Summary
SelectQuote, Inc. reported consolidated revenue of $232.7 million for Q1 FY2024, compared to $162.5 million in Q1 FY2023. The net loss for Q1 FY2024 was $31.1 million, an improvement from a net loss of $42.5 million in Q1 FY2023. Adjusted EBITDA for Q1 FY2024 was $(11.4) million, compared to $(27.5) million in Q1 FY2023. The company reaffirmed its FY2024 guidance ranges, with expected revenue between $1.05 billion and $1.2 billion, a net loss between $50 million and $22 million, and adjusted EBITDA between $80 million and $105 million.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.97%
Tags
Rhea-AI Summary
SelectQuote, Inc. announces the release of its first quarter financial results and upcoming Sidoti conference presentation. The financial results will be released on November 2, 2023, followed by a conference call to discuss the results. The company will also present at Sidoti's Virtual Microcap Conference on November 15, 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.83%
Tags
-
Rhea-AI Summary
SelectQuote, Inc. reported Q4 FY2023 revenue of $221.8 million, a net loss of $(47.8) million, and adjusted EBITDA of $(5.8) million. FY2024 revenue expected to be between $1.05 billion and $1.2 billion, net loss between $50 million and $22 million, and adjusted EBITDA between $80 million and $105 million.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-16.18%
Tags
-
Rhea-AI Summary
SelectQuote, Inc. will release its Q4 and full year 2023 financial results on September 13, 2023. CEO and CFO will host a conference call to discuss the results. Registration is open through the live call.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.56%
Tags
Rhea-AI Summary
SelectQuote's full-service medication management pharmacy, SelectRx, has been accredited for Patient-Centered Pharmacy Home by The Compliance Team. This accreditation recognizes the pharmacy's advanced pharmacy practices for chronically ill patients. SelectRx received Exemplary Provider® status, TCT’s exclusive accreditation designation.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.58%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-20%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.25%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.44%
Tags
SelectQuote Inc

NYSE:SLQT

SLQT Rankings

SLQT Stock Data

288.98M
138.17M
10.25%
45.57%
0.37%
Insurance Agencies and Brokerages
Finance and Insurance
Link
United States
Overland Park

About SLQT

the selectquote difference over 25 years ago, selectquote pioneered a new way to buy term life insurance - providing unbiased price comparisons of your best rates from highly-rated term life insurance companies. your personal selectquote agent is dedicated to: • answering all your questions. • offering all the information you need to be an informed buyer. • diligently shopping for your best prices from the trusted companies selectquote represents. • going to bat for you every step of the way. • selectquote's breakthrough technology has helped streamline what can be a lengthy and involved application process. today, selectquote is america's #1 term life sales agency. the trusted companies we represent every life insurance company selectquote represents has been carefully chosen to provide favorable rates for people with certain risks. that's why we can provide attractive rates to people who smoke or take meds to control cholesterol, blood pressure or other health issues